Pharmafile Logo
Pharmafocus logo
Advanced Search

LEO Pharma appoints new executive vice president

February 29, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing LEO Pharma, supply chain

From March Anders Spohr will take over the position of executive vice president for global product supply at LEO Pharma. …

Appointment

NHS must adopt new technologies faster, says minister

February 28, 2012
Research and Development ABPI, NHS, Whitehead, Willetts, innovation

The NHS needs to speed up its adoption of new technology, according to universities and science minister David Willetts. Echoing …

News

ICON acquires market access consultancy

February 28, 2012
Research and Development CRO, ICON, pharma market access, pricing and reimbursement

ICON has acquired consulting firm PriceSpective, helping to expand the contract research organisation’s services in the field of pricing and …

News
Sir David Nicholson

Doctors don’t want rationing responsibility, finds survey

February 28, 2012
Sales and Marketing Commissioning Board, NHS, NHS reforms, NHSCB, NICE, rationing

 A survey of GPs in England has found that most do not want powers to ration care for NHS patients.The …

News

Jon Linscott to head PAN Advertising

February 28, 2012
Business Services, Medical Communications, Sales and Marketing Creston Health, Jon Linscott, Pan Advertising

Jon Linscott has been appointed managing director of PAN Advertising, a member of the Creston Health group of companies.   Linscott …

Appointment
GSK picture

GSK recalls Novartis’ blood pressure drug

February 28, 2012
Manufacturing and Production DynaCirc CR, GSK, Novartis

GlaxoSmithKline is the latest company to be affected by manufacturing glitches at Novartis’ troubled facility in Lincoln, Nebraska, having been …

News

EMA confirms verdict on Ben Venue facility

February 28, 2012
Manufacturing and Production Ben Venue, CHMP, EMA, Sanofi

The European Medicines Agency has officially removed Ben Venue Laboratories’ troubled Bedford facility as an approved location for the manufacture …

News
Shire image

Shire’s Vpriv plant wins EU approval

February 28, 2012
Manufacturing and Production EMA, Shire, Vpriv

Shire has been told by the European Medicines Agency that it can make use of a manufacturing facility in Lexington, …

News
Glivec

Glivec cleared for longer use in GIST patients

February 28, 2012
Sales and Marketing Europe, GIST, Gleevec, Glivec, Novartis

Glivec has gained EU approval for extended use after surgery for adults with KIT (CD117)-positive gastrointestinal stromal tumours (GIST).The drug …

News
Lilly picture

Lilly plans €330m biomanufacturing plant in Ireland

February 28, 2012
Manufacturing and Production Abbott, Ireland, Kinsale, lilly

There was more good news for Ireland’s pharmaceutical sector this week with the announcement by Eli Lilly that it will …

News

Endo says Opana ER supply disruption will be temporary

February 28, 2012
Manufacturing and Production Endo, Novartis, Opana ER

Endo Pharmaceuticals has said that current supply restrictions for its new Opana ER formulation of oxymorphone are likely to be …

News

Priorclave Introduce Autoclave Application Selector at Arab Lab

February 27, 2012
Manufacturing and Production

It is not unexpected to find that senior managers from British autoclave manufacturer Priorclave will be making their way East …

News
Press release

Witty hits out at ‘systematic delays’ to medicines

February 27, 2012
Sales and Marketing Europe, GSK, NICE, austerity

 GlaxoSmithKline’s chief executive says Europe’s drug budget cuts are undermining the industry and not addressing the biggest cost pressure in …

News

Janssen launches hep C support programme

February 27, 2012
Medical Communications, Sales and Marketing BUPA, Copegas, Incivo, Janssen, Pegasys, hep C

Janssen has launched a hepatitis C support programme for patients in the UK to help with medicine adherence and healthy …

News

On-going Medicine evaluation Information to be published by European Medicines Agency

February 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA), …

News
Press release

EMA accepts Genzyme MS drug for review

February 24, 2012
Research and Development, Sales and Marketing EMA, Genzyme, Sanofi, teriflunomide

The European Medicines Agency has accepted Genzyme’s application for its multiple sclerosis pill teriflunomide.  Genzyme, which is wholly owned by …

News
werner_wenning_bayer

Werner Wenning proposed as chairman of the supervisory board at Bayer

February 24, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Schneider, Wenning

Former Bayer chief executive Werner Wenning is set to be elected to the supervisory board at Bayer with effect from October. …

Appointment

Care regulator chief steps down

February 24, 2012
Sales and Marketing CQC, Cynthia Bower, Mid Staffs, reforms

The head of the Care Quality Commission Cynthia Bower has resigned from her post, amid growing pressure from the government. …

News
Genzyme picture

Genzyme to close UK site

February 24, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, UK, job cuts

Genzyme will close its Cambridge R&D site by the end of the year, with a loss of around 60 jobs.  …

News

The NHS, a postcard from the frontline

February 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brighton, NHS, Sussex, reforms

It is January 2012, and the NHS in England is under huge strain. This is because it is being asked …

Feature
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026